Consensus Nomenclature for in vivo Imaging of Reversibly Binding Radioligands

…, S Houle, SC Huang, M Ichise… - Journal of Cerebral …, 2007 - journals.sagepub.com
Consensus Nomenclature for in vivo Imaging of Reversibly Binding Radioligands - Robert B
Innis, Vincent J Cunningham, Jacques Delforge, Masahiro Fujita, Albert Gjedde, Roger N …

Linearized Reference Tissue Parametric Imaging Methods: Application to [11C]DASB Positron Emission Tomography Studies of the Serotonin Transporter in Human …

M Ichise, JS Liow, JQ Lu, A Takano… - Journal of Cerebral …, 2003 - journals.sagepub.com
The authors developed and applied two new linearized reference tissue models for parametric
images of binding potential (BP) and relative delivery (R 1 ) for [ 11 C]DASB positron …

Strategies to improve neuroreceptor parameter estimation by linear regression analysis

M Ichise, H Toyama, RB Innis… - Journal of Cerebral …, 2002 - journals.sagepub.com
In an attempt to improve neuroreceptor distribution volume (V) estimates, the authors evaluated
three alternative linear methods to Logan graphical analysis (GA): GA using total least …

[PDF][PDF] High-contrast in vivo imaging of tau pathologies in Alzheimer's and non-Alzheimer's disease tauopathies

…, SK Mishra, Y Yamaguchi, Y Kimura, M Ichise… - Neuron, 2021 - cell.com
A panel of radiochemicals has enabled in vivo positron emission tomography (PET) of tau
pathologies in Alzheimer's disease (AD), although sensitive detection of frontotemporal lobar …

Combination of dopamine transporter and D2 receptor SPECT in the diagnostic evaluation of PD, MSA, and PSP

YJ Kim, M Ichise, JR Ballinger, D Vines… - … : official journal of the …, 2002 - Wiley Online Library
It is often difficult to differentiate clinically between Parkinson's disease (PD), multiple system
atrophy (MSA), and progressive supranuclear palsy (PSP).The objective of this work was to …

Metformin in amnestic mild cognitive impairment: results of a pilot randomized placebo controlled clinical trial

…, J Steffener, G Pradabhan, M Ichise… - Journal of …, 2016 - content.iospress.com
Diabetes and hyperinsulinemia may be risk factors for Alzheimer’s disease (AD). We conducted
a pilot study of metformin, a medication efficacious in treating and preventing diabetes …

Elevated serotonin transporter binding in major depressive disorder assessed using positron emission tomography and [11C] DASB; comparison with bipolar disorder

DM Cannon, M Ichise, D Rollis, JM Klaver… - Biological …, 2007 - Elsevier
BACKGROUND: Altered serotonergic function is thought to play a role in the pathophysiology
of major depressive episodes based upon evidence from neuroimaging, pharmacological, …

Evaluation of anesthesia effects on [18F] FDG uptake in mouse brain and heart using small animal PET

H Toyama, M Ichise, JS Liow, DC Vines… - Nuclear medicine and …, 2004 - Elsevier
This study evaluates effects of anesthesia on 18 F-FDG (FDG) uptake in mouse brain and
heart to establish the basic conditions of small animal PET imaging. Prior to FDG injection, 12 …

PET imaging of the dopamine transporter with 18F-FECNT: a polar radiometabolite confounds brain radioligand measurements

SS Zoghbi, HU Shetty, M Ichise, M Fujita… - Journal of Nuclear …, 2006 - Soc Nuclear Med
18 F-2β-Carbomethoxy-3β-(4-chlorophenyl)-8-(2-fluoroethyl)nortropane ( 18 F-FECNT), a
PET radioligand for the dopamine transporter (DAT), generates a radiometabolite that enters …

Serotonin transporter binding in bipolar disorder assessed using [11C] DASB and positron emission tomography

DM Cannon, M Ichise, SJ Fromm, AC Nugent… - Biological …, 2006 - Elsevier
BACKGROUND: Evidence from neuroimaging post-mortem, and genetic studies suggests
that bipolar disorder (BD) is associated with abnormalities of the serotonin-transporter (5-HTT) …